• 42 Citations
  • 4 h-Index
20162019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Daniele Di Carlo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
HIV-1 Medicine & Life Sciences
Rilpivirine Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
Canrenone Medicine & Life Sciences
Reverse Transcriptase Inhibitors Medicine & Life Sciences
Klebsiella Infections Medicine & Life Sciences
Mineralocorticoid Receptor Antagonists Medicine & Life Sciences
Galectin 3 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 42 Citations
  • 4 h-Index
  • 13 Article

Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors

Scutari, R., Alteri, C., Vicenti, I., Di Carlo, D., Zuccaro, V., Incardona, F., Borghi, V., Bezenchek, A., Andreoni, M., Antinori, A., Perno, C. F., Cascio, A., De Luca, A., Zazzi, M. & Santoro, M. M., Jul 19 2019, In : Journal of Global Antimicrobial Resistance. p. 1-7 7 p.

Research output: Contribution to journalArticle

Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study

Modica, S., Redi, D., Gagliardini, R., Giombini, E., Bezenchek, A., Di Carlo, D., Maggiolo, F., Lombardi, F., Borghetti, A., Farinacci, D., Callegaro, A., Gismondo, M. R., Colafigli, M., Sterrantino, G., Costantini, A., Ferrara, S. M., Rusconi, S., Zazzi, M., Rossetti, B., De Luca, A. & 1 others, Gianotti, N., Oct 11 2019, In : The Journal of antimicrobial chemotherapy. 75, 1, p. 1-6 6 p.

Research output: Contribution to journalArticle

Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen

ICONA Foundation Study group, Jan 1 2019, In : Antiviral Therapy. 24, 5, p. 321-331 11 p.

Research output: Contribution to journalArticle

Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence

Alteri, C., Fabeni, L., Scutari, R., Berno, G., Di Carlo, D., Gori, C., Bertoli, A., Vergori, A., Mastrorosa, I., Bellagamba, R., Mussini, C., Colafigli, M., Montella, F., Pennica, A., Mastroianni, C. M., Girardi, E., Andreoni, M., Antinori, A., Svicher, V., Ceccherini-Silberstein, F. & 2 others, Perno, C. F. & Santoro, M. M., Oct 24 2018, In : Scientific Reports. 8, 1

Research output: Contribution to journalArticle

1 Citation (Scopus)

New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T)

Pouga, L., Santoro, M. M., Charpentier, C., Di Carlo, D., Romeo, I., Artese, A., Alcaro, S., Antinori, A., Wirden, M., Perno, C. F., Ambrosio, F. A., Calvez, V., Descamps, D., Marcelin, A. G., Ceccherini-Silberstein, F. & Lambert-Niclot, S., Aug 13 2018, In : Chemical Biology and Drug Design.

Research output: Contribution to journalArticle

Reverse Transcriptase Inhibitors
Lamivudine
Nucleosides
Codon
Patient treatment